SCHEMBL1033751

SCHEMBL1033751

Clc1ccnc(NC2CCCCC2)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.60
KDM4E B2RXH2 1/20 0.59
GAA P10253 1/20 0.59
HRH4 Q9H3N8 3/20 0.51
CDK1 P06493 5/20 0.50
CDK2 P24941 5/20 0.50
MAPK8 P45983 4/20 0.50
MAPK9 P45984 4/20 0.50
CCNB1 P14635 4/20 0.50
CDK4 P11802 3/20 0.50
CCNA2 P20248 3/20 0.50
CCND1 P24385 3/20 0.50
CCNA1 P78396 3/20 0.50
MAPK10 P53779 2/20 0.50
CDC7 O00311 2/20 0.48
MAP4K4 O95819 2/20 0.48
INSR P06213 2/20 0.48
PRKACA P17612 2/20 0.48
FLT1 P17948 2/20 0.48
KDR P35968 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18920813 1.00 CTSK (0.60) CTSKKDM4EGAAHRH4CDK1
SCHEMBL3451468 0.98 CTSK (0.58) CTSKKDM4EGAAHRH4CDK1
SCHEMBL29770915 0.91 IKBKB (0.50) CTSKKDM4EGAAHRH4CDK2
SCHEMBL3579494 0.85 IKBKB (0.46) CTSKKDM4EGAAHRH4CDK1
SCHEMBL21143601 0.81 IDH1 (0.58) MAPK10ROCK2IKBKB
SCHEMBL31127411 0.81 IDH1 (0.58) MAPK10ROCK2IKBKB
SCHEMBL27109893 0.80 GPR39 (0.58) CTSKKDM4EGAAHRH4CDK1
SCHEMBL91484 0.79 CTSK (0.60) CTSKKDM4EGAAHRH4CDK1
SCHEMBL19098459 0.79 MKNK1 (0.52) CTSKHRH4CDK2MAPK8MAPK9
SCHEMBL20606073 0.79 CTSK (0.60) CTSKKDM4EGAAHRH4CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102471345-A Pyrrolopyrazine inhibitors of kinases ABBOTT LAB 2012-05-23 CN disclosed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed